A murine Niemann-Pick C1 I1061T knock-In model recapitulates the pathological features of the most prevalent human disease allele

Maria Praggastis, Brett Tortelli, Jessie Zhang, Hideji Fujiwara, Rohini Sidhu, Anita Chacko, Zhouji Chen, Chan Chung, Andrew P. Lieberman, Jakub Sikora, Cristin Davidson, Steven U. Walkley, Nina H. Pipalia, Frederick R. Maxfield, Jean E. Schaffer, Daniel S. Ory

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Niemann-Pick Type C1 (NPC1) disease is a rare neurovisceral, cholesterol–sphingolipid lysosomal storage disorder characterized by ataxia, motor impairment, progressive intellectual decline, and dementia. The most prevalent mutation, NPC1 <sup>I1061T</sup>, encodes a misfolded protein with a reduced half-life caused by ER-associated degradation. Therapies directed at stabilization of the mutant NPC1 protein reduce cholesterol storage in fibroblasts but have not been tested in vivo because of lack of a suitable animal model. Whereas the prominent features of human NPC1 disease are replicated in the null Npc1 <sup>-/-</sup> mouse, this model is not amenable to examining proteostatic therapies. The objective of the present study was to develop an NPC1 I1061T knock-in mouse in which to test proteostatic therapies. Compared with the Npc1 <sup>-/-</sup> mouse, this Npc1tm(I1061T)Dso model displays a less severe, delayed form of NPC1 disease with respect to weight loss, decreased motor coordination, Purkinje cell death, lipid storage, and premature death. The murine NPC1 <sup>I1061T</sup> protein has a reduced half-life in vivo, consistent with protein misfolding and rapid ER-associated degradation, and can be stabilized by histone deacetylase inhibition. This novel mouse model faithfully recapitulates human NPC1 disease and provides a powerful tool for preclinical evaluation of therapies targeting NPC1 protein variants with compromised stability.

Original languageEnglish (US)
Pages (from-to)8091-8106
Number of pages16
JournalJournal of Neuroscience
Volume35
Issue number21
DOIs
StatePublished - May 27 2015

Fingerprint

Type C Niemann-Pick Disease
Alleles
Proteins
Half-Life
Premature Mortality
Histone Deacetylases
Purkinje Cells
Ataxia
Therapeutics
Dementia
Weight Loss
Cell Death
Animal Models
Fibroblasts
Cholesterol
Lipids
Mutation

Keywords

  • Cholesterol
  • Lysosomal storage
  • Neurodegeneration
  • Niemann-Pick C
  • NPC1
  • Protein misfolding

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

A murine Niemann-Pick C1 I1061T knock-In model recapitulates the pathological features of the most prevalent human disease allele. / Praggastis, Maria; Tortelli, Brett; Zhang, Jessie; Fujiwara, Hideji; Sidhu, Rohini; Chacko, Anita; Chen, Zhouji; Chung, Chan; Lieberman, Andrew P.; Sikora, Jakub; Davidson, Cristin; Walkley, Steven U.; Pipalia, Nina H.; Maxfield, Frederick R.; Schaffer, Jean E.; Ory, Daniel S.

In: Journal of Neuroscience, Vol. 35, No. 21, 27.05.2015, p. 8091-8106.

Research output: Contribution to journalArticle

Praggastis, M, Tortelli, B, Zhang, J, Fujiwara, H, Sidhu, R, Chacko, A, Chen, Z, Chung, C, Lieberman, AP, Sikora, J, Davidson, C, Walkley, SU, Pipalia, NH, Maxfield, FR, Schaffer, JE & Ory, DS 2015, 'A murine Niemann-Pick C1 I1061T knock-In model recapitulates the pathological features of the most prevalent human disease allele', Journal of Neuroscience, vol. 35, no. 21, pp. 8091-8106. https://doi.org/10.1523/JNEUROSCI.4173-14.2015
Praggastis, Maria ; Tortelli, Brett ; Zhang, Jessie ; Fujiwara, Hideji ; Sidhu, Rohini ; Chacko, Anita ; Chen, Zhouji ; Chung, Chan ; Lieberman, Andrew P. ; Sikora, Jakub ; Davidson, Cristin ; Walkley, Steven U. ; Pipalia, Nina H. ; Maxfield, Frederick R. ; Schaffer, Jean E. ; Ory, Daniel S. / A murine Niemann-Pick C1 I1061T knock-In model recapitulates the pathological features of the most prevalent human disease allele. In: Journal of Neuroscience. 2015 ; Vol. 35, No. 21. pp. 8091-8106.
@article{ed20b7390330453aa6f97ae14ffe1ee8,
title = "A murine Niemann-Pick C1 I1061T knock-In model recapitulates the pathological features of the most prevalent human disease allele",
abstract = "Niemann-Pick Type C1 (NPC1) disease is a rare neurovisceral, cholesterol–sphingolipid lysosomal storage disorder characterized by ataxia, motor impairment, progressive intellectual decline, and dementia. The most prevalent mutation, NPC1 I1061T, encodes a misfolded protein with a reduced half-life caused by ER-associated degradation. Therapies directed at stabilization of the mutant NPC1 protein reduce cholesterol storage in fibroblasts but have not been tested in vivo because of lack of a suitable animal model. Whereas the prominent features of human NPC1 disease are replicated in the null Npc1 -/- mouse, this model is not amenable to examining proteostatic therapies. The objective of the present study was to develop an NPC1 I1061T knock-in mouse in which to test proteostatic therapies. Compared with the Npc1 -/- mouse, this Npc1tm(I1061T)Dso model displays a less severe, delayed form of NPC1 disease with respect to weight loss, decreased motor coordination, Purkinje cell death, lipid storage, and premature death. The murine NPC1 I1061T protein has a reduced half-life in vivo, consistent with protein misfolding and rapid ER-associated degradation, and can be stabilized by histone deacetylase inhibition. This novel mouse model faithfully recapitulates human NPC1 disease and provides a powerful tool for preclinical evaluation of therapies targeting NPC1 protein variants with compromised stability.",
keywords = "Cholesterol, Lysosomal storage, Neurodegeneration, Niemann-Pick C, NPC1, Protein misfolding",
author = "Maria Praggastis and Brett Tortelli and Jessie Zhang and Hideji Fujiwara and Rohini Sidhu and Anita Chacko and Zhouji Chen and Chan Chung and Lieberman, {Andrew P.} and Jakub Sikora and Cristin Davidson and Walkley, {Steven U.} and Pipalia, {Nina H.} and Maxfield, {Frederick R.} and Schaffer, {Jean E.} and Ory, {Daniel S.}",
year = "2015",
month = "5",
day = "27",
doi = "10.1523/JNEUROSCI.4173-14.2015",
language = "English (US)",
volume = "35",
pages = "8091--8106",
journal = "Journal of Neuroscience",
issn = "0270-6474",
publisher = "Society for Neuroscience",
number = "21",

}

TY - JOUR

T1 - A murine Niemann-Pick C1 I1061T knock-In model recapitulates the pathological features of the most prevalent human disease allele

AU - Praggastis, Maria

AU - Tortelli, Brett

AU - Zhang, Jessie

AU - Fujiwara, Hideji

AU - Sidhu, Rohini

AU - Chacko, Anita

AU - Chen, Zhouji

AU - Chung, Chan

AU - Lieberman, Andrew P.

AU - Sikora, Jakub

AU - Davidson, Cristin

AU - Walkley, Steven U.

AU - Pipalia, Nina H.

AU - Maxfield, Frederick R.

AU - Schaffer, Jean E.

AU - Ory, Daniel S.

PY - 2015/5/27

Y1 - 2015/5/27

N2 - Niemann-Pick Type C1 (NPC1) disease is a rare neurovisceral, cholesterol–sphingolipid lysosomal storage disorder characterized by ataxia, motor impairment, progressive intellectual decline, and dementia. The most prevalent mutation, NPC1 I1061T, encodes a misfolded protein with a reduced half-life caused by ER-associated degradation. Therapies directed at stabilization of the mutant NPC1 protein reduce cholesterol storage in fibroblasts but have not been tested in vivo because of lack of a suitable animal model. Whereas the prominent features of human NPC1 disease are replicated in the null Npc1 -/- mouse, this model is not amenable to examining proteostatic therapies. The objective of the present study was to develop an NPC1 I1061T knock-in mouse in which to test proteostatic therapies. Compared with the Npc1 -/- mouse, this Npc1tm(I1061T)Dso model displays a less severe, delayed form of NPC1 disease with respect to weight loss, decreased motor coordination, Purkinje cell death, lipid storage, and premature death. The murine NPC1 I1061T protein has a reduced half-life in vivo, consistent with protein misfolding and rapid ER-associated degradation, and can be stabilized by histone deacetylase inhibition. This novel mouse model faithfully recapitulates human NPC1 disease and provides a powerful tool for preclinical evaluation of therapies targeting NPC1 protein variants with compromised stability.

AB - Niemann-Pick Type C1 (NPC1) disease is a rare neurovisceral, cholesterol–sphingolipid lysosomal storage disorder characterized by ataxia, motor impairment, progressive intellectual decline, and dementia. The most prevalent mutation, NPC1 I1061T, encodes a misfolded protein with a reduced half-life caused by ER-associated degradation. Therapies directed at stabilization of the mutant NPC1 protein reduce cholesterol storage in fibroblasts but have not been tested in vivo because of lack of a suitable animal model. Whereas the prominent features of human NPC1 disease are replicated in the null Npc1 -/- mouse, this model is not amenable to examining proteostatic therapies. The objective of the present study was to develop an NPC1 I1061T knock-in mouse in which to test proteostatic therapies. Compared with the Npc1 -/- mouse, this Npc1tm(I1061T)Dso model displays a less severe, delayed form of NPC1 disease with respect to weight loss, decreased motor coordination, Purkinje cell death, lipid storage, and premature death. The murine NPC1 I1061T protein has a reduced half-life in vivo, consistent with protein misfolding and rapid ER-associated degradation, and can be stabilized by histone deacetylase inhibition. This novel mouse model faithfully recapitulates human NPC1 disease and provides a powerful tool for preclinical evaluation of therapies targeting NPC1 protein variants with compromised stability.

KW - Cholesterol

KW - Lysosomal storage

KW - Neurodegeneration

KW - Niemann-Pick C

KW - NPC1

KW - Protein misfolding

UR - http://www.scopus.com/inward/record.url?scp=84930260924&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930260924&partnerID=8YFLogxK

U2 - 10.1523/JNEUROSCI.4173-14.2015

DO - 10.1523/JNEUROSCI.4173-14.2015

M3 - Article

VL - 35

SP - 8091

EP - 8106

JO - Journal of Neuroscience

JF - Journal of Neuroscience

SN - 0270-6474

IS - 21

ER -